# Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy

> **NCT01445613** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 1203 (actual)

## Conditions studied

- Carotid Artery Disease
- Stroke
- Amaurosis Fugax
- Transient Ischemic Attack (TIA)

## Interventions

- **DEVICE:** RX Acculink Carotid Stent System (RX Acculink)

## Key facts

- **NCT ID:** NCT01445613
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2014-12
- **Final completion:** 2016-03
- **Target enrollment:** 1203 (ACTUAL)
- **Last updated:** 2016-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01445613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01445613, "Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01445613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*